bromocriptine has been researched along with trihexyphenidyl in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (36.84) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ringwald, E | 1 |
Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Suitsu, N | 1 |
Cooper, JA; Jordan, N; Sagar, HJ | 1 |
Nakashima, K; Takahashi, K | 1 |
Onodera, K; Shinoda, H | 1 |
Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y | 1 |
Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N | 1 |
Angelini, L; Broggi, G; Caraceni, T; Giovannini, P; Girotti, F; Nardocci, N; Scigliano, G | 1 |
Alonso, RJ; Covington, TR; Mancall, EL | 1 |
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O | 1 |
Brown, D; Factor, SA; Molho, ES; Podskalny, GD | 1 |
Kishore, A; Snow, BJ | 1 |
de Saint-Martin, A; Hirsch, E; Marescaux, C; Picard, F; Salmon, E | 1 |
Okamoto, K; Tanaka, M | 1 |
Au-Yeung, KM; Chan, KH; Cheng, TS; Cheung, RT; Ho, SL; Mak, W | 1 |
Hirohata, M; Ono, K; Yamada, M | 1 |
2 review(s) available for bromocriptine and trihexyphenidyl
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl | 1996 |
4 trial(s) available for bromocriptine and trihexyphenidyl
Article | Year |
---|---|
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl | 1978 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl | 1992 |
13 other study(ies) available for bromocriptine and trihexyphenidyl
Article | Year |
---|---|
A component analysis of the generation and release of isometric force in Parkinson's disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl | 1992 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl | 1987 |
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1985 |
Idiopathic dystonia: neuropharmacological study.
Topics: Adolescent; Adult; Aged; Bromocriptine; Dystonia; Female; Humans; Male; Middle Aged; Pimozide; Syndrome; Torticollis; Trihexyphenidyl | 1982 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine | 1994 |
The effect of dancing on dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; Trihexyphenidyl; Vitamin E | 1996 |
Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Encephalitis; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D2; Stereotyped Behavior; Tomography, X-Ray Computed; Trihexyphenidyl | 1996 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl | 2003 |
Wilson's disease with depression and parkinsonism.
Topics: Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Penicillamine; Suicide, Attempted; Tomography, X-Ray Computed; Trientine; Trihexyphenidyl | 2005 |
Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Topics: alpha-Synuclein; Antiparkinson Agents; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Molecular Structure; Neurofibrillary Tangles; Pergolide; Polymers; Selegiline; Trihexyphenidyl | 2007 |